Cargando…
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurveys can estimate cumulative incidence for monitoring epidemics, requiring assessment of serologic assays to inform testing algorithm development and interpretation of results. We conducted a multilaboratory evaluation of 21 commerc...
Autores principales: | Stone, Mars, Grebe, Eduard, Sulaeman, Hasan, Di Germanio, Clara, Dave, Honey, Kelly, Kathleen, Biggerstaff, Brad J., Crews, Bridgit O., Tran, Nam, Jerome, Keith R., Denny, Thomas N., Hogema, Boris, Destree, Mark, Jones, Jefferson M., Thornburg, Natalie, Simmons, Graham, Krajden, Mel, Kleinman, Steve, Dumont, Larry J., Busch, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888213/ https://www.ncbi.nlm.nih.gov/pubmed/35202525 http://dx.doi.org/10.3201/eid2803.211885 |
Ejemplares similares
-
Evaluation of Ortho VITROS and Roche Elecsys S and NC Immunoassays for SARS-CoV-2 Serosurveillance Applications
por: Sulaeman, Hasan, et al.
Publicado: (2023) -
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program
por: Stone, Mars, et al.
Publicado: (2021) -
SARS Antibody Test for Serosurveillance
por: Hsueh, Po-Ren, et al.
Publicado: (2004) -
Plans for Nationwide Serosurveillance Network in Vietnam
por: Anh, Dang Duc, et al.
Publicado: (2020) -
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
por: Nicholson, Suellen, et al.
Publicado: (2021)